These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36066461)

  • 1. Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Koyuncu CF; Nag R; Lu C; Corredor G; Viswanathan VS; Sandulache VC; Fu P; Yang K; Pan Q; Zhang Z; Xu J; Chute DJ; Thorstad WL; Faraji F; Bishop JA; Mehrad M; Castro PD; Sikora AG; Thompson LDR; Chernock RD; Lang Kuhs KA; Wasman JK; Luo JR; Adelstein DJ; Koyfman SA; Lewis JS; Madabhushi A
    Cancer; 2022 Nov; 128(21):3831-3842. PubMed ID: 36066461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
    Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
    J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifactorial estimation of clinical outcome in HPV-associated oropharyngeal squamous cell carcinoma via automated image analysis of routine diagnostic H&E slides and neural network modelling.
    Hue J; Valinciute Z; Thavaraj S; Veschini L
    Oral Oncol; 2023 Jun; 141():106399. PubMed ID: 37098302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution's experience.
    Jiromaru R; Yasumatsu R; Yamamoto H; Kuga R; Hongo T; Nakano T; Manako T; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3717-3725. PubMed ID: 34978590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Treatment Parameters on Racial Survival Differences in Oropharyngeal Cancer: National Cancer Database Study.
    Zhu D; Wong A; Oh EJ; Ahn S; Wotman M; Sahai T; Bottalico D; Frank D; Tham T
    Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1134-1143. PubMed ID: 34399637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients.
    Koyuncu CF; Frederick MJ; Thompson LDR; Corredor G; Khalighi S; Zhang Z; Song B; Lu C; Nag R; Sankar Viswanathan V; Gilkey M; Yang K; Koyfman SA; Chute DJ; Castro P; Lewis JS; Madabhushi A; Sandulache VC
    Oral Oncol; 2023 Aug; 143():106459. PubMed ID: 37307602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
    Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
    Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.
    Corredor G; Toro P; Koyuncu C; Lu C; Buzzy C; Bera K; Fu P; Mehrad M; Ely KA; Mokhtari M; Yang K; Chute D; Adelstein DJ; Thompson LDR; Bishop JA; Faraji F; Thorstad W; Castro P; Sandulache V; Koyfman SA; Lewis JS; Madabhushi A
    J Natl Cancer Inst; 2022 Apr; 114(4):609-617. PubMed ID: 34850048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of human papillomavirus detection and the eighth edition of the TNM classification staging system in oropharyngeal squamous cell carcinoma: A single-center Polish study.
    Durzynska M; Kiprian D; Szumera-Cieckiewicz A; Leszczynski P; Florek A; Snietura M; Michalek IM; Bakula-Zalewska E; Prochorec-Sobieszek M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):698-705. PubMed ID: 35165063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.
    Wilde DC; Castro PD; Bera K; Lai S; Madabhushi A; Corredor G; Koyuncu C; Lewis JS; Lu C; Frederick MJ; Frederick AM; Haugen AE; Zevallos JP; Sturgis EM; Shi J; Huang AT; Hernandez DJ; Skinner HD; Kemnade JO; Yu W; Sikora AG; Sandulache VC
    Mod Pathol; 2022 Aug; 35(8):1045-1054. PubMed ID: 35184149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
    Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
    Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
    Settle K; Posner MR; Schumaker LM; Tan M; Suntharalingam M; Goloubeva O; Strome SE; Haddad RI; Patel SS; Cambell EV; Sarlis N; Lorch J; Cullen KJ
    Cancer Prev Res (Phila); 2009 Sep; 2(9):776-81. PubMed ID: 19641042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.